Treatment for Covid-19 approved in Europe, Japan

By Red Mendoza

Sep 23, 2022 12:11 am

(UPDATE) AN antibody cocktail for the treatment of Covid-19 among adults and adolescents has been approved in the European Union and Japan, according to its manufacturer, AstraZeneca.

The AZD7442 cocktail combines two long-acting antibodies — tixagevimab and cilgavimab — which was derived from B-cells donated by convalescent patients after infection from Covid-19.

AstraZeneca vaccines are one of the most effective protection against the Covid-19 virus. CONTRIBUTED PHOTO

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

Suspected Chinese spy arrested

Court convicts ex-QC mayor Herbert Bautista of graft

Gordon Ramsay: 'Philippines sleeping beauty of Asia'

Billionaires' wealth soared in 2024

Marcos leads launch of Tesla Motors PH

Parents to QC court: Start trial of Dengvaxia cases

Fuel prices up for 3rd straight week